Financial Disclosure Statement

MSACL 2018 US Abstract Title:
Increasing Throughput for High Analytical Sensitivity Bioanalysis of Human Insulin and its Biotherapeutic Analogs Using Microflow LC-MS/MS for Clinical Research
Andrew Peck
Waters Corporation

DescriptionY/NSource
Grantsno
SalaryyesWaters Corporation
Board Memberno
Stockyes Waters Corporation
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no